# Corvus Pharmaceuticals, Inc.: Form 8-K, filed Apr 23, 2026

- Company: [Corvus Pharmaceuticals, Inc.](/companies/crvs.md) (CIK 1626971)
- Form: 8-K
- Filed: 2026-04-23
- Accepted by EDGAR: Apr 23, 2026, 16:30 ET
- Period: 2026-04-22
- Accession: 0001104659-26-047735
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1626971/000110465926047735/crvs-20260422x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1626971/000110465926047735/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1626971/000110465926047735/crvs-20260422x8k.htm

Filed Apr 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-047735. Last ingested by Listed: Nov 5, 2026, 16:49 ET. No prices; not investment advice.